Category Archives: Ralf Paus

Monasterium Laboratory

According to Monasterium Laboratory’s news page, they moved into a brand new research facility in 2018. It is located in this modern nanobiotech research hub.

Monasterium Laboratory
Monasterium Laboratory.

Monasterium Laboratory in Germany

Recently, I stumbled upon the website of a new company that Dr. Paus has started in Germany called Monasterium Laboratory Skin & Hair Research Solutions. Although the company started in 2015, it seems like their website only came on-stream in 2016. Update: They now have a new Youtube channel.

On the website, they have a blurry image of the earlier mentioned study on the olfactory receptor (specifically, the OR2AT4 receptor) in one of the rotating banners on top. Apparently the company even released a product in Italy in 2017 called Bioscalin Signal Revolution and it supposedly stimulates the OR2AT4 receptor. If any of you readers frequent the major Italian hair loss forums out there, I would be curious as to what they think about this product.

Another interesting study that the Monasterium team has published recently concludes that the antidepressant Fluoxetine (Prozac) promotes human hair follicle pigmentation and could prevent grey hair formation. This is interesting and surprising, because there have also been some reports that SSRIs such as Prozac can cause hair loss in some patients.


During the course of my research for this post, I read this wikipedia entry on Dr. Paus’ wife (with parts of it also involving Dr. Paus). There seems to be some controversy regarding their past work. Nevertheless, this does not seem to have prevented Monasterium Laboratory from having a pretty solid list of advisers and collaboration partners.

Among Monasterium’s clients include the below ones that I have covered a number of times on this blog.

The US, Japan and Germany seem to be leading global hair loss research. Germany has been lagging the other two of late, so I am glad about this new addition in that country.